Michael Feigh
Impact in
-
- Diet, Metabolism, and Disease
- Diabetes Treatment and Management
- Hepatology top 5%
Papers in
- Epidemiology 37
- Liver Disease Diagnosis and Treatment 34
-
- Metabolism, Diabetes, and Cancer 10
- Peroxisome Proliferator-Activated Receptors 5
- Fibroblast Growth Factor Research 4
- Co-authors
- Sanne Skovgård Veidal (27 shared papers)Niels Vrang (17 shared papers)Henrik H. Hansen (20 shared papers)Jacob Jelsing (12 shared papers)Kristoffer T.G. Rigbolt (3 shared papers)K.S. Tølbøl (9 shared papers)Keld Fosgerau (2 shared papers)Kristoffer Rigbolt (8 shared papers)
- Journals
- Journal of Hepatology (12 papers)Diabetes (5 papers)Scientific Reports (4 papers)British Journal of Pharmacology (3 papers)Hepatology Communications (3 papers)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Michael Feigh
57 papers receiving 1.5k citations
Michael Feigh's Hit Papers
Peers
Comparison fields: 5 of 69
- Endocrinology, Diabetes and Metabolism 508
- Hepatology 225
- Epidemiology 857
- Endocrine and Autonomic Systems 65
- Cell Biology 167
Countries citing papers authored by Michael Feigh
This map shows the geographic impact of Michael Feigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Feigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Feigh more than expected).
Fields of papers citing papers by Michael Feigh
This network shows the impact of papers produced by Michael Feigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Feigh. The network helps show where Michael Feigh may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Feigh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis Hit paper breakdown → | 2020 | 212 |
| 2 | 2017 | 194 | |
| 3 | 2018 | 116 | |
| 4 | 2016 | 102 | |
| 5 | 2021 | 98 | |
| 6 | 2019 | 91 | |
| 7 | 2014 | 64 | |
| 8 | 2018 | 64 | |
| 9 | 2022 | 52 | |
| 10 | 2019 | 46 | |
| 11 | 2020 | 41 | |
| 12 | 2011 | 39 | |
| 13 | 2022 | 37 | |
| 14 | 2021 | 35 | |
| 15 | 2015 | 31 | |
| 16 | 2021 | 25 | |
| 17 | 2012 | 23 | |
| 18 | 2023 | 22 | |
| 19 | 2013 | 20 | |
| 20 | 2018 | 19 |
About Michael Feigh
Michael Feigh is a scholar working on Epidemiology, Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery and Physiology, having authored 64 papers that have together received 1.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (34 papers), Metabolism, Diabetes, and Cancer (10 papers), Diet, Metabolism, and Disease (10 papers), Adipose Tissue and Metabolism (7 papers), Pancreatic function and diabetes (6 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Diabetes Treatment and Management (4 papers) and Fibroblast Growth Factor Research (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (508 citations), Hepatology (225 citations), Epidemiology (857 citations), Endocrine and Autonomic Systems (65 citations) and Cell Biology (167 citations). Michael Feigh has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Sanne Skovgård Veidal, Niels Vrang, Henrik H. Hansen, Jacob Jelsing, Kristoffer T.G. Rigbolt, K.S. Tølbøl, Keld Fosgerau, Kristoffer Rigbolt, Jonathan D. Roth and Kim Henriksen. Their work appears in journals such as Journal of Hepatology, Diabetes, Scientific Reports, British Journal of Pharmacology and Hepatology Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.